ACQUAVIVA, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 404
NA - Nord America 188
AS - Asia 42
OC - Oceania 1
SA - Sud America 1
Totale 636
Nazione #
US - Stati Uniti d'America 186
GB - Regno Unito 125
DE - Germania 94
IE - Irlanda 58
SE - Svezia 43
RU - Federazione Russa 26
CN - Cina 25
UA - Ucraina 23
IT - Italia 12
FR - Francia 10
SG - Singapore 7
FI - Finlandia 5
BE - Belgio 4
GR - Grecia 4
IN - India 4
CA - Canada 2
JP - Giappone 2
AR - Argentina 1
AU - Australia 1
GE - Georgia 1
IR - Iran 1
TH - Thailandia 1
TR - Turchia 1
Totale 636
Città #
Southend 121
Dublin 58
Chandler 25
Ann Arbor 21
Jacksonville 19
Fairfield 16
Ashburn 14
Wilmington 11
Woodbridge 9
Houston 8
Mestre 8
Princeton 8
Düsseldorf 6
New York 6
Beijing 5
Nanjing 5
Singapore 5
Brussels 4
Cambridge 4
Nellore 4
Siena 4
Boardman 3
Dearborn 3
Jiaxing 3
San Diego 3
Seattle 3
Shenyang 3
Hebei 2
Kunming 2
Monmouth Junction 2
Nanchang 2
Andover 1
Billingham 1
Buenos Aires 1
Chiswick 1
Durham 1
Fuzhou 1
Helsinki 1
Irving 1
Jinan 1
Kashan 1
Kilburn 1
Los Angeles 1
Melbourne 1
Norwalk 1
Nürnberg 1
Ottawa 1
Paris 1
Preston 1
Tappahannock 1
Tokyo 1
Toronto 1
Totale 408
Nome #
Down-Regulation of NOX4 Expression by Roflumilast N-oxide Reduces Markers of Fibrosis in Lung Fibroblasts 180
Pinosilvin administered in monotherapy and in combination with methotrexate reduces oxidative stress in adjuvant arthritis rat model 175
Signalling pathways involved in isoprostane-mediated fibrogenic effects in rat hepatic stellate cells 150
Roflumilast N-oxide, a PDE4 inhibitor, inhibits fibrotic changes induced by isoprostanes in human lung fibroblasts 136
Totale 641
Categoria #
all - tutte 1.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 5 16 8 10 4 9 3 6
2020/202195 13 9 9 13 2 7 5 14 8 4 7 4
2021/202268 6 9 0 8 5 0 4 3 9 5 7 12
2022/202383 7 10 12 12 10 16 5 1 8 0 1 1
2023/202473 2 1 3 1 3 25 38 0 0 0 0 0
2024/202538 2 6 20 7 3 0 0 0 0 0 0 0
Totale 641